HBSAG SEROCOVERSION UNDER LAMIVUDINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B

被引：0
|
作者：
Seven, Gulseren
Idilman, Ramazan
Bozkus, Yusuf
Cinar, Kubilay
Kabacam, Gokhan
Yakut, Mustafa
Bozdayi, A. Mithat [1 ]
Yurdaydin, Cihan [1 ]
机构：
[1] Ankara Univ, Fac Med, Inst Hepatol, TR-06100 Ankara, Turkey
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
453
引用
收藏
页码：545A / 546A
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 409 - 419
  • [42] Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase
    Chen, Li
    Shi, Junjie
    Lu, Zhonghua
    Ye, Yun
    Zhou, Xinbei
    Tan, Youwen
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) : 310 - 316
  • [43] Durable HBeAg and HBsAg seroconversions after lamivudine for chronic hepatitis B (CHB)
    Schiff, E
    Cianciara, J
    Karayalcin, S
    Kowdley, K
    Woessners, M
    McMullens, S
    Pearce, M
    Browns, N
    JOURNAL OF HEPATOLOGY, 2000, 32 : 99 - 99
  • [44] EFFECTIVENESS OF LONG-TERM COMBINATION THERAPY WITH ADEFOVIR DIPIVOXIL AND LAMIVUDINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B AND LAMIVUDINE RESISTANCE
    Manolakopoulos, Spilios
    Striki, Athanasia
    Papatheodoridis, George V.
    Deutsch, Melanie
    Mela, Maria
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    HEPATOLOGY, 2009, 50 (04) : 520A - 521A
  • [45] Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B
    Lampertico, P
    Vigano, M
    Manenti, E
    Lunghi, G
    Iavarone, M
    Del Ninno, E
    Colombo, M
    JOURNAL OF HEPATOLOGY, 2005, 42 : 182 - 182
  • [46] Combination of adefovir dipivoxil with lamivudine vs. adefovir alone in lamivudine-resistant HBeAg-negative chronic hepatitis B patients
    Rapti, Irene N.
    Dimou, Evangelini
    Mitsoula, Panayota
    Hadziyannis, Stephanos J.
    HEPATOLOGY, 2006, 44 (04) : 558A - 559A
  • [47] Real-world study on HBsAg loss of combination therapy in HBeAg-negative chronic hepatitis B patients
    Chu, Jun-Hao
    Huang, Yan
    Xie, Dong-Ying
    Deng, Hong
    Wei, Jia
    Guan, Yu-Juan
    Li, Guo-Jun
    Zeng, Yi-Lan
    Yang, Jia-Hong
    Chen, Xin-Yue
    Shang, Jia
    Li, Jia-Bin
    Gao, Na
    Gao, Zhi-Liang
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (09) : 765 - 776
  • [48] HBV DNA and HBsAg: Early Prediction of Response to Peginterferon α-2a in HBeAg-Negative Chronic Hepatitis B
    Zhang, Chong
    Yang, Zhengrong
    Wang, Ziyi
    Dou, Xiaoguang
    Sheng, Qiuju
    Li, Yanwei
    Han, Chao
    Ding, Yang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (03): : 383 - 389
  • [49] Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients
    Ungtrakul, Teerapat
    Sriprayoon, Tassanee
    Kusuman, Pattama
    Chunnuan, Pitchayachuda
    Soonklang, Kamonwan
    Somsamdang, Gaidganok
    Auewarakul, Chirayu U.
    Tanwandee, Tawesak
    MEDICINE, 2017, 96 (13)
  • [50] Treatment paradigms in hepatitis B e antigen negative (HBeAg-negative) chronic hepatitis B patients
    Hadziyannis, S. J.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S15 - S15
12345